SpecialtiesQuestion

Would you consider using luspatercept in a patient with CMML-1 with anemia refractory to HMA?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How do you sequence luspatercept and imetelstat for treatment of anemia in MDS?

What is your preferred first-line treatment regimen for patients with high-risk MDS?

How do you modify HMA treatments for a patient with high-risk MDS experiencing prolonged cytopenias after each cycle?

How do you approach imetelstat therapy in MDS patients with baseline neutropenia or thrombocytopenia?

Which neoadjuvant/adjuvant chemotherapy regimen would you select in a patient with resectable stage IB pancreatic head adenocarcinoma and MDS-SF3B1 on luspatercept (baseline Hgb of 8-9 g/dL)?

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.